Humanized antibodies are antibodies from non-human species whose protein sequences have been modified to increase their similarity to antibody variants produced naturally in humans. The process of "humanization" is usually applied to monoclonal antibodies developed for administration to humans (for example, antibodies developed as anti-cancer drugs).
| Attributes | Values |
|---|---|
| rdfs:comment |
|
| foaf:depiction | |
| thumbnail | |
| is product of |